“Green Fairies” are a symptom of unmet demand

A media release from Medical Cannabis Awareness NZ:


“Green Fairies” are a symptom of unmet demand

On Newshub’s 6 o’clock news last night, it was revealed 2 of the larger compassionate supplier’s aka “Green Fairies” are being prosecuted by the police, to the detriment of hundreds (potentially thousands) of patients.

“With over 140k people estimated to use Cannabis at least sometimes for medical purposes illicitly, it is no surprise that there are a growing number of compassionate suppliers in both quantity, and scope of their operations”.

“With the continued failure at the political level to resolve legal supply of safe sterilized Cannabis based products that a sickness beneficiary can actually afford, these people will be seen as martyrs and heroes to the patient community, and unfortunately it reflects poorly on the police”.

“The police seem quite able to turn a blind eye to the dealing of Class B Cannabis based products if your name was Helen Kelly, however the mere act of cultivating a C drug is viewed as a heinous crime that is beyond police discretion.”

“Police Discretion is an empty promise by Politicians to dodge the issue, Police I have dealt with fear setting a precedent by exercising discretion” says MCANZ Coordinator Shane Le Brun.

“MCANZ would like to see a political solution far more ambitious and detailed than provided by either of the major parties. We look to Canada as an excellent example to follow, where Cannabis products are so affordable that less than 2% of Medical Cannabis users seek permits to grow their own.

“Cannabis-based products are relatively simple, It’s just another Essential Oil.

“The Current regime ensures that only expensive products will be vaguely available, and that means patients will continue to break the law, often with the support of their specialists, and making criminals of otherwise law-abiding citizens.

“The costs are so high that I am aware of GPs and Specialists that are referring patients to “Green Fairies”.

“This is a direct response to increasing acceptance of its medical benefit, and the refusal to accept the cost of Sativex which is borne solely by patients”.

The domestic market in Canada is considered by MCANZ to be the closest model to ideal, where products are prescribed by GPs, and the cost per mg of active ingredients are 80% less of what is paid in New Zealand currently. Nevertheless, MCANZ is committed to advocating for patients for legal access in the current system, which can take over a year of advocacy to gain approval under the non pharmaceutical scheme and then months extra again to arrange import.

Shane Le Brun
Medical Cannabis Awareness Coordinator
http://www.mcawarenessnz.org

Cheaper medicinal cannabis product approved

The only legal medicinal cannabis product available in New Zealand until now has been Sativex, a mouth spray that has been prohibitively expensive for many people.

Another product that is less than half the price, Tilray, has just been approved by Associate Health Minister Peter Dunne after Dr Huhana Hickey applied to use it.

NZ Herald: Medicinal cannabis costs set to tumble after cheaper product gets green light

It is estimated the marijuana-based tincture called Tilray will cost at least 50 per cent less than the existing legal product Sativex, a UK mouth spray made by GW Pharma.

Multiple sclerosis sufferer, Dr Huhana Hickey, who applied to use Tilray, said: “I’m so relieved. It’s going to save me $700 a month.”

The AUT academic says she has spent $9000 on prescriptions since she started taking medicinal cannabis in February. Hickey says the results have been remarkable.

“I’m living my life again. I’m back to work, I am fully-functioning”

She started using the spray to replace pain killers such as morphine, codeine, tramadol and other opiates which she had been prescribed for years.

“At the start I was sceptical I didn’t think it was going to work that well, but I can’t believe it. I haven’t had opiates for seven months. It really works and I have no side effects.”

Hickey says she doesn’t get high, just a little dozy at nights.
“And I sleep, which is great because I’ve been an insomniac for 40 years.”

Medicinal cannabis is being used to treat diverse conditions such as chronic pain, terminal cancer, Tourette’s and child epilepsy. Patients say it reduces the severity of their symptoms.

Sativex, which is not funded by the drug buying agency Pharmac, has been available in New Zealand since 2008. Medical marijuana campaigners say fewer than 40 patients use it, largely because of the price. A prescription through a district health board costs patients around $1200 a month, or $1500 if it is ordered with a chemist.

Hickey’s success follows the rejection of a similar application by trade unionist Helen Kelly. She wanted to use a cannabis product to alleviate symptoms of terminal lung cancer. Kelly, 52, died on Friday.

Kelly’s application was rejected and she didn’t try again, instead choosing to illegally use medicinal cannabis, openly flaunting the law.

The campaigning charity Medical Cannabis Awareness NZ supported Hickey’s application for the new concentrate.

Spokesman Shane Le Brun said: “There are many people suffering while waiting for legal access, who balk at the price of Sativex. We hope that Tilray products will be recognised over time as a ‘close enough’ equivalent to Sativex to spare patients the exorbitant cost.”

Le Brun says the other reason for the lack of uptake of Sativex the difficulty in finding an anaesthetist who will agree to prescribing medicinal cannabis. He hopes this decision will change things.

“Once we have a few more approvals through then specialists will have less room to squirm and avoid the issue.”

Le Brun hopes that eventually new cannabis medicines will not require ministerial sign off.

Dunne would not comment but his office indicated that in the future approval for recognised products such as Tilray was likely to become routine.

“Hopefully this will open door for others in need,” says Hickey.

It’s a toe in the door. Now Hickey’s application has succeeded expect more people to apply to use Tilray.

First DHB funded Sativex

A post from MZaNZ:

BREAKING NEWS: First Patient in NZ Successfully funded for Sativex by DHB

A woman who may have otherwise died from her regular severe seizures has been granted approval for medical marijuana funding.

Alisha Butt, 20, has the mentality of a toddler and is unable to speak.

Her seizures had presented a huge problem for specialists who were unable to adequately treat her, leading to the possibility she could end up in a coma from one and die.

But thanks to medicinal marijuana extract Sativex, Alisha is able to live a more comfortable life.

“Since being on Sativex for over 4 months, she has shown a great improvement,” mum Sushila Butt said.

“Her seizures have decreased immensely and now, after long last, Alisha has been able to enjoy a better quality of life without the disturbance of erratic and continuous prolonged seizures.”

A big relief to see a significant improvement.

Then, in September, Alisha was approved by the minister of Health to receive Sativex – which contains Cannabidiol with Tetrahydrocannabinol, or THC, the main psychoactive component of cannabis – but the family had to fund the $1000-a-month treatment themselves.

It wasn’t until January 22 that the Government agreed to fund the medicinal marijuana as a prescription.

“It’s completely covered now,” Sushila said. “It will be fully funded for my daughter.

A funding breakthrough. Until now Sativex wasn’t funded and was costing something like $1000 per month, too much for many parents.

Full post at MCaNZ:
http://mcadvocacynz.org/2016/01/28/breaking-news-first-patient-in-nz-successfully-funded-for-sativex/

Government moves to legalise growing medicinal cannabis…

…in Australia. But changes there will put further pressure on the Government in New Zealand to look at similar changes here.

Government moves to legalise growing medicinal cannabis in Australia

The Federal Government has announced it will legalise the growing of cannabis for medicinal purposes.

Health Minister, Sussan Ley, says the Government wants to give people suffering from debilitating illnesses access to the most effective medical treatments.

Medicinal cannabis can already be provided under a special scheme, but Ms Ley says global supplies are relatively scarce and expensive.

SUSSAN LEY: I have heard stories of patients who resorted to illegal methods of obtaining cannabis and I have felt for them because with a terminal condition the most important thing is quality of life and relief of pain and we know that many people are calling out for medicinal cannabis.

It is important therefore that we recognise those calls for help, that we put in place what we know will support a safe, legal and sustainable supply of a product.

LOUISE YAXLEY: The Government intends to amend the Narcotic Drugs Act to allow cannabis to be grown for medicine or science, and that would ensure that Australia is not in breach of international drug treaties.

SUSSAN LEY: This is not a debate about legalisation of cannabis, this is not about drugs, this is not a product you smoke, this has nothing to do with that. 

Most commonly the product is an oil or a tincture that you put on your skin.

The shadow assistant Health Minister, Stephen Jones, said Labor would have a nationally consistent scheme.

STEPHEN JONES: It’s a truly national scheme to make medicinal cannabis available and it shouldn’t be a matter of whether you live in New South Wales or Victoria or somewhere else in Australia – if you are suffering from a terminal illness or if your child has drug resistant epilepsy, suffering from life threatening fits, then you should have available to you through medical advice and appropriate channels, medicinal cannabis.

Forget Dunne, I think he’s pushing as hard as he can in a difficult situation. He’s copping all the pressure, but the thing holding up faster change here is National.

Pressure John Key and target National MPs who might look favourable and compassionately on looking at better ways of alleviating the suffering of people.

Like Zoe Jeffries , a 7 year old girl with uncontrolled epilepsy, spastic quadriplegia cerebral palsy, microcephaly, cerebral visual impairment, is tube fed and who has had severe seizures since birth.

After two years her parents have got Ministry of Health approval to use the only available cannabis derived medicine in New Zealand, Sativex. At a cost to them of $250 per week. See Ministry of Health approves medicinal cannabis treatment.

For much to happen this term National need to change their intransigence substantially.

It would also help if the Greens and Labour pushed far more strongly and positively on this.

And public pressure needs to be strong but positive, a slanging match won’t change anything for the better.

Ministry of Health approves medicinal cannabis treatment

The parents of 7 year old girl Zoe Jeffries have obtained Ministry of Health approval fore 6 months use of Sativex. This is one of a total of 97 ministerial approvals for the cannabis derived medicine. It shows that it is possible now to get medicinal cannabis, although it isn’t easy.

And it isn’t cheap – Zoe’s parents are fund raising to try and cover the costs. See the bottom of this post for details.

It’s also far from easy caring for a girl with uncontrolled epilepsy, spastic quadriplegia cerebral palsy, microcephaly, cerebral visual impairment, is tube fed and who has had severe seizures since birth.

It shouldn’t be this difficult getting medicines that may help.

NZ Herald reports Ministry approves cannabis treatment for 7-year-old girl:

The parents of a 7-year-old girl have the green light to use medicinal cannabis to control their daughter’s severe seizures.

Karen and Adam Jeffries have Health Ministry approval to give their daughter Zoe the cannabis oil-based mouth spray Sativex for the next six months.

“It has been a long time coming, it’s great news,” mum Karen Jeffries told the Herald on Sunday.

The Jeffries began researching medical cannabis in 2013 in the hope of finding a drug to reduce the hundreds of seizures their daughter suffers each day.

Two years is a long time to obtain a medicine that may help. And there is only one cannabis based medicine currently available in New Zealand. It may or may not be the most appropriate to try.

The Rotorua girl is understood to be one of the youngest in New Zealand to receive the medicine. Another child, a 5-year-old, has been approved use.

“We have been on it for a couple of weeks so it is early days but she is a lot more settled already.”

“You want to try to control the seizures that cause additional brain damage, but also you want to allow your child a life, to be awake and not drowsy, or have the strength to stand or just hold their head up high,” her father Adam said.

The medicine hadn’t dramatically changed the number of seizures Zoe suffers but this week, teachers at Glenholme School in Rotorua said she returned to school happier.

“When she started school this week they saw a completely different child,” Karen Jeffries said. “She was a lot more settled and was able to cope with noise and was a lot less distressed.”

It’s a lot to hope for a miracle cure for such serious medical problems, but parents should be able to hope for some improvement in their child’s condition. It’s good to see that that may be being achieved.

But it is expensive for the Jeffries.

Sativex is the only approved cannabis-based medicine registered with Pharmac but is not funded. It can be prescribed by a doctor but each case needs Health Ministry approval. To date, there have been 97 ministerial approvals, and there are currently 27 users of Sativex.

Each bottle lasts around four weeks and costs $1050. The Jeffries paid for the first script with a well-timed tax return and have set up a Givealittle page to help fund repeat scripts.

Givealittle ‘Meds for Zoe’: Please help Zoe continue with the chance at a better quality of life…

For information on medicinal cannabis in New Zealand: United in Compassion

United In Compassion NZ is a non profit lobby for the re-introduction of Medicinal Cannabis and a community for patients and carers. We are on a journey to access medicinal cannabis through Education, Compassion and Logic.

Pharmac to consider cannabis spray funding

NZ Herald reports Cannabis spray considered for public funding:

A cannabis spray used to treat epilepsy, pain and multiple sclerosis will be considered for public funding next month.

Pharmac, the agency responsible for deciding which medicines get subsidised, plans to discuss the Sativex spray with its primary clinical advisory committee, according to a letter from Pharmac released on Friday.

Pharmac said Sativex contained cannabidiol with tetrahydrocannabinol, or THC, the main psychoactive component of cannabis.

The agency said consideration from the Pharmacology and Therapeutics Advisory Committee was the first step in assessing the funding of a new medicine.

According to Medsafe, Sativex was already approved for use in New Zealand as “an add-on treatment” for some patients with moderate to severe spasticity due to multiple sclerosis.

Specifically, it could be given to people who hadn’t responded adequately to other anti-spasticity medication and who showed improvement in spasticity-related symptoms during an initial trial of therapy.

Any other use of Sativex was currently banned.

One small step forward perhaps.

Dunne: find a doctor who is open to medicinal cannabis

Peter Dunne has been reported as effectively encouraging patients wanting to use medicinal cannabis to find a doctor who will consider this in their interest.

This is in Mum desperate for medicinal cannabis for her sick son:

Associate Minister of Health Peter Dunne has made it clear to GPs and the Medical Association that conservatism about using medicinal cannabis isn’t always in the best interests of their patients.

If a doctor wasn’t open to medicinal cannabis then families had the option of finding another doctor, he said.

“I’m not going to encourage or discourage that because it’s not my role, but it’s an option for them to consider.”

This looks like a carefully worded but significant statement from Dunne. This was in response to discussion about other parents wanting to try medical cannabis for their children because other drugs weren’t helping and follows the approval of the Ministry and Dunne to allow Alex Renton to be treated with Elixinol.

His family’s fight to get doctors to apply to the Ministry of Health has triggered another mother, Julie Dixon, to share her experiences battling for CBD for her son, Matthew.

The Christchurch 27-year-old has suffered from refractory epilepsy since he was aged 3 and has spent much of his life in and out of a hospital.

“We’re desperate,” Dixon said.

Matthew’s seizures are uncontrolled by medication and he too has spent time in hospital in an induced coma.

The Government allows oral treatment of a drug called Sativex, which contains cannabis extracts that include CBD and requires ministerial approval.

When Dunne approved Elixinol for Alex Renton it was the first time that particular product had been approved.

“The last time we visited the specialist we asked about Sativex and the doctor’s response was, why would you want to try that when it hasn’t been proven to work,” Dixon said.

“For us there is an absence of any other treatment options. We are regularly advised there is nothing left.”

Dixon said doctors have never discussed anything outside of conventional treatments with her and it was only when she started doing her own research she came across Sativex and Elixinol.

She and her husband, Kelvin, have written to Dunne asking for approval but without the support of Matthew’s doctor, Dunne is hamstrung by the procedure, which isn’t one he plans to change.

“At the end of the day cannabis oil is just another drug – no different from the powerful drugs being used to keep Alex comatose and the powerful drug that our son Matthew takes every day of his life, which does not control his seizures,” she said.

And Dunne seems to be following these cases and recognises the difficulties the families are having with treatments.

While Dunne said he had considerable sympathy for the families involved, “I’m not a clinician and I’m not in any position to override the clinical judgment.”

But he is open to broadening access to medicinal cannabis despite Prime Minister John Key saying he wouldn’t support a parliamentary debate on the matter.

“We are watching closely the trials that are being undertaken in Australia. Essentially if they prove to be effective we would obviously seek to take advantage of them in New Zealand.

“But the real issue beyond that is manufacturers being prepared to make those drugs available, in some cases they’re not interested because they don’t see the market as big enough.”

For it to go beyond a case by basis a manufacturer would have to apply for interim or general approval of use of their products here.

Perhaps the New Zealand market isn’t big enough – but if a manufacturer had their products approved in the New Zealand market and proved their worth here that would do a lot to help them establish wider markets.

Sativex or CBD for teenager coma treatment?

A very sad case in Stuff – Family’s desperate quest for cannabis oil – with a teenager in a coma for 54 days and his family denied treatment they hope might help where nothing else has.

Nelson teen Alex Renton was hospitalised in early April after a serious seizure. He has been in an induced coma in Wellington’s intensive care unit since April 8.

Alex remains in ‘status epilepticus’, a kind of prolonged seizure.

Despite a barrage of tests, the underlying cause remains unknown, although doctors suspect some variety of auto-immune encephalitis. Two attempts to wake him and multiple varieties of anti-epileptic medication have failed to make an impact.

An awful situation for the nineteen year old and very difficult for his family.

With a recommendation from one of Alex’s neurologists, his family are now keen to try something new – a cannabinoid oil (CBD) extracted from marijuana that international research has endorsed as a treatment for seizures. But accessing the oil, even with the support of a neurologist, has proved nearly impossible.

As Alex is legally an adult, his mother needed to gain authority over Alex’s medical decisions. After 36 hours in the Wellington District Court she was granted interim guardianship.

Neurologist Ian Rosemergy endorsed her attempt, writing in a letter that it “should at least be considered”.

“We understand that this is outside the normal parameters of the management of status epilepticus however this is the family’s wishes and we are happy to support them in this,” he said.

So a neurologist thinks it’s ok to try or at least consider another form of treatment but that might be impossible.

 New Zealand has no clinical standard for the oil, meaning no hospital will happily administer it.

Even getting the oil into the country would require considerable effort.

“It’s illegal to produce medicinal cannabis in New Zealand, so you have to do it overseas, but it’s at a horrendous price”” said Renton. She was given a quote of US$3000 (NZ$4200) for 100ml of the oil.

“Then getting it through the governmental side and the political side will be almost impossible. [

“Families shouldn’t have to fight. I shouldn’t have to fight to get what Alex needs.”

There’s no guarantee it would help but nothing currently available has helped so far.

Minister of Health spokesman Peter Abernethy clarified the Government’s position.

“Policy over successive governments has been to not support the use of leaf cannabis or cannabis oil for medicinal use,” he said.

“This position is supported by there being questions over the standardisation and potencies of natural cannabis, and the availability of pharmaceutical forms of cannabis as approved medicines.”

There seems to be a resistance to using any medication with any association with cannabis. There is one cannabis extract drug available but ironically it has an intoxicating effect.

The Government allows oral treatment of a drug called Sativex, which contains cannabis extracts that include CBD. Ministerial approval is required, and the drug is expensive, but it is legal.

Renton is wary of the higher THC content in Sativex. THC is the intoxicating agent in marijuana.

“He is already so sedated with medical drugs. I don’t want him to wake up in that state, but I may have no other choice,” Renton said.

“This isn’t just about Alex. There are thousands of people who could benefit from medicinal marijuana grown in New Zealand.”

I don’t know whether New Zealand health authorities just have an anal attitude to anything related to cannabis or if they are exercising normal medical caution on drugs with insufficient research available.

But it’s not as if there’s no history of the effects of cannabis, it’s one of the most widely used drugs in New Zealand, which as a country is one of the biggest users of cannabis in the world – illegally.

But it appears that there may be insufficient medical evidence to be sure about the safety or efficacy of CBD.

Dravet syndrome is a rare form of epilepsy that is difficult to treat. Dravet syndrome, also known as severe myoclonic epilepsy of infancy (SMEI), is a rare and catastrophic form of intractable epilepsy that begins in infancy. Initial seizures are most often prolonged events and in the second year of life other seizure types begin to emerge.

While high profile and anecdotal reports of results from high-CBD/low-THC preparations have sparked interest in treatment with cannabinoids, there is insufficient medical evidence to draw conclusions about their safety or efficacy.

This makes it very difficult for Alex Renton’s parents. It is an awful situation for them to be in, knowing (or at least hoping) there could be something that could help their son but with little hope of being allowed to try it.

The family remains committed to obtaining CBD, setting up a Change.Org petition to pressure the Government, gaining over 400 signatures. A GiveALittle Page has allowed the Nelson community to support the seven-child Renton family as Alex’s coma has continued.

The petition currently has 13,897 supporters (7:40 am, June 1).

John Key is nowhere to be seen on medical use, although he recently stated “I just don’t agree with drugs”.

Prime Minister John Key has ruled out relaxing cannabis laws while campaigning for the Northland by-election.

In response to a question from a voter Mr Key said he did not support decriminalisation of cannabis.

The voter accused Mr Key of wanting to lock people up in jail.

“It’s not so much that, I just don’t agree with drugs,” the Prime Minister said.

Except alcohol.

The Children’s Commissioner (who happens to be a doctor) “says New Zealand should be trialling medicinal cannabis for children” – Commissioner calls for medicinal cannabis trials.

Children’s Commissioner Dr Russell Wills says New Zealand should be trialling medicinal cannabis for children.

His comments come as an eleven-year-old girl becomes the first New Zealand child to be prescribed medicinal cannabis extract, called Sativex.

Sativex has been approved for Multiple Sclerosis and chronic pain sufferers.

But its use – untested for a child – has Dr Wills worried. He says Sativex may have side effects for children including sedation and hallucinations

“We know those side effects can be pretty substantial,” he says.

Because of those fears, he says some parents are breaking the law to make another form of cannabis oil they believe is far safer.

“Parents are bringing it in themselves because they are desperate for a solution to a devastating disease.

“The right solution is to enrol those children in an international trial.”

The situation is changing quite quickly overseas.

Medical cannabis: Norfolk Island decision sparks renewed calls to legalise drug for Australian patients

A decision to grant a licence to grow medicinal cannabis on Norfolk Island has sparked renewed calls for the drug to be made available to Australian patients.

Cannabis producer AusCann has become the first Australian company to be granted a license to grow and export medicinal cannabis to an international market.

The company will grow medicinal cannabis on Norfolk Island and export it for sale in Canada.

The company said it hoped it would soon be able to export medicinal cannabis to mainland Australia, with legislation due to come before Federal Parliament in the coming months.

But Australian review jeopardises Norfolk Island medicinal cannabis export deal

A landmark deal to grow a high-strain medicinal cannabis on Norfolk Island for export to Canada is in jeopardy, with the Australian government reviewing the decision.

But Support grows for medical marijuana before Federal Parliament vote.

More than two-thirds of Australians back the use of medicinal cannabis, according to a new survey likely to bolster support among MPs and senators who are set to vote on the issue in the coming months.

Palliative Care Australia has found 67 per cent of people are happy to see the drug used to help patients with chronic pain and illness – and support is strongest among the elderly.

The survey found people in older age brackets were more supportive of legalisation than the young: 72 per cent of 75 to 84-year-olds are in favour, compared to 62 per cent of 18 to 24-year-olds.

The survey of 1006 people from across the country found just 9 per cent of Australians oppose the use of medicinal cannabis. About a quarter – 24 per cent – say they are not sure.

An unlike New Zealand there seems to be a willingness to allow the use of medical cannabis by their politicians:

The results will further add to the momentum behind a legalisation bill currently before the federal parliament.

The bill would make the federal government responsible for overseeing the production, distribution and use of medicinal cannabis.

A Senate inquiry into the bill is set to report back to Parliament next month. The bill looks likely to pass into law, particularly given Prime Minister Tony Abbott threw his support behind the legalisation last year.

“I have no problem with the medical use of cannabis just as I have no problem with the medical use of opiates,” he said.

In the US there has been many changes to legislation over the past eighteen months with various degrees of availability of or research into CBD – CBD Oil Now Legal in 14 States (with four more “on the verge”)

Alabama On Apr. 1, 2014, Gov. Robert Bentley signed Carly’s Law. The bill calls for the University of Alabama to conduct research into cannibidiol’s efficacy in treating neurological conditions such as epilepsy. UAB would be able to prescribe the oil to approved patients.

Florida On Apr. 22, 2014, HB 843 passed the House Judiciary Committee by a 15-3 vote. The bill calls for “four regional orginizations around the state” to “grow, test and dispense” the oil. A patient registry would be created. Unlike other CBD legislation, HB 843 is not limited to seizure conditions; patients with Parkinson’s, Alzheimer’s, PTSD and cancer would also qualify.

Georgia CBD oil legislation known as Haleigh’s Hope Act, failed to receive a Senate vote after sailing through Georgia’s House on Mar. 4, 2014. However, in May, Gov. Nathan Deal signed an executiuve order calling for a study. The British firm GW Pharmaceuticals and Georgia Regents University are collaborating on the research. The legislation was reintroduced for the 2015 session. The House passed it on Mar, 25, 2015. The bill covers eight conditions, including seizures, cancer, MS, ALS, sickle cell and mitchondria.

Idaho On Apr. 7, 2015, the Idaho House approved a CBD oil bill by a close 39-30 vote. Named for 11-year-old epilepsy patient Alexis Carey, the legislation would allow parents to possess up to 32 fluid ounces of liquid cannabidiol (max 15% CBD and .03% THC) to administer to chilldren who suffer from seizure disorders. On Apr. 16, Gov. Butch Otter vetoed the bill. However, he says he’ll issue an executive order requiring the state’s Department of Health and Welfare to study the effects of CBD oil on epilepsy; this may lead to access to the oil for children.

Iowa On Apr. 9, 2014, the House Public Safety Committee passed a CBD oil bill by a 13-5 margin. The legislation, already been approved by the Senate, is strictly intended for patients with epilepsy or other seizure disorders. It allows for possession of a six-months supply (32 ounces) and calls for the University of Iowa to conduct a CBD study. Patients will need to go out-of-state (presumably to Colorado) to acquire the oil.

Kentucky On Apr. 11, 2014, Gov. Steve Beshear signed SB 124 into law. On Mar. 12, Kentucky’s Senate unanimously approved the bill. On Mar, 26, the House did the same. The new law allows the University of Kentucky and University of Louisville med schools to conduct research into CBD oil and provide it to patients enrolled in the trial program.

MIssissippi  On Apr. 17, 2014, Gov. Phil Bryant signed a bill named which calls for the National Center for Natural Products Research in Oxford to produce the medicine.

Missouri  On May 1, 2014, the Missouri House (136-12) and Senate (unanimous) passed CBD-only leglislation.The bill directs the state’s Department of Agricultiure to set up a system for non-profit applicants to produce the oil under Health and Senior Services guidelines. Patients who suffer from seizures must prove that other treatment regimens have failed.

New York On June 3, 2014, Gov. Andrew Cuomo announced that the state has entered into an agreement with GW Pharmaceuticals to investigate the efficacy of cannabidiol use by children suffering from the seizure disorders Dravet’s syndrome and Lennox-Gastuat syndrome. The clinical trials will take place at hospitals, universities and medical colleges. GW is already working with NYU’s Langone Medical Center on a trial involving 60 children and their CBD product, Epidiolex. New York passed a broader medical marijuana bill on June 20.

North Carolina  On June 27, 2014 the state legislature passed CBD-oil bills. The legislation calls for a trial study to be conducted by the state’s top four universities – UNC, Duke, Wake Forest and East Carolina. Th primary focus is making making the oil available to youngsters who suffer from seizures. Neurologists are responsible for providing the medicine.

Oklahoma On Apr. 30, 2015, Gov. Mary Fallon signed legislation making Oklahoma the 14th state to legalize CBD oil“This bill will help get sick children potentially life-changing medicine,” Fallin started. “By crafting the legislation in a way that allows for tightly controlled medical studies, we can ensure we are researching possible treatments in a responsible and scientific way. It is not marijuana, and it is not anything that can make you high. This law has been narrowly crafted to support highly supervised medical trials for children with debilitating seizures.”

South Carolina CBD oil legislation passed South Carolina’s House (92-5) and Senate (unanimous), and became law on May 28, 2014. The bill requires a clinical trial to be established at the University of South Carolina.

Tennessee Last May, Gov. Bill Haslam signed a bill that directs Tennessee Tech University to create a research program to study the efficacy of CBD oil used to prevent seizures. The University is required to provide oil to other schools of medicine. All research must be completed by 2018.

Utah On Mar. 25, 2014, Utah Gov. Gary Herbert signed HB 105 into law, making Utah the first state to legalize CBD oil. On Mar. 11, Utah’s Senate unanimously passed the bill which instructs the state’s Department to Agriculture to grow low-THC industrial hemp for the purpose of producing cannabis oil. Known as the “Plants Extracts Amendment,” the bill allows Utah residents to acquire the medicine in Colorado and bring it back to Utah.

Virginia After sailing through Virginia’s Senate, the House version of SB 1235 received a unanimous 98-0 vote in favor on Feb. 10. The bill prevents patients from being prosecuted for using cannabis oil for seizure-related conditions.

Wisconsin  On Apr. 16, 2014, Gov. Scott Walker signed  AB 726 into law. It’s unclear where and by whom the oil is going to be produced.

In New Zealand we seem to have a clash of Government caution and parent desperation.